5985-38-6

5985-38-6 structure
5985-38-6 structure

Name l-3-hydroxy-n-methylmorphinan dihydrate
Synonyms LEVORPHANOL TARTRATE SALT
LEVORPHANOL TARTRATE
levorphanol tartrate dihydrate
LEVORPHANOLTARTRATE,USP
levorphanol tartrate methanol solution
L-3-HYDROXY-N-METHYLMORPHINAN
Boiling Point 410.4ºC at 760 mmHg
Molecular Formula C21H33NO9
Molecular Weight 443.48800
Flash Point 11ºC
Exact Mass 443.21600
PSA 156.99000
LogP 0.76710

CHEMICAL IDENTIFICATION

RTECS NUMBER :
QD1924200
CAS REGISTRY NUMBER :
5985-38-6
LAST UPDATED :
199012
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C17-H23-N-O.C4-H6-O6.2H2-O
MOLECULAR WEIGHT :
443.55
WISWESSER LINE NOTATION :
T6 G665/FP 2AF P FX ONT&TTJ IQ O1 &QVYQYQVQ &QH 2

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
135 mg/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - effect, not otherwise specified Behavioral - altered sleep time (including change in righting reflex) Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 85,387,1951
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
45 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - dyspnea
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 85,387,1951
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
23 mg/kg
TOXIC EFFECTS :
Behavioral - altered sleep time (including change in righting reflex) Lungs, Thorax, or Respiration - dyspnea Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 85,387,1951
Symbol GHS06 GHS08
GHS06, GHS08
Signal Word Danger
Hazard Statements H301-H312 + H332-H317-H334-H360
Precautionary Statements Missing Phrase - N15.00950417-P201-P261-P280-P284-P308 + P313
Personal Protective Equipment Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges
Hazard Codes T,F
Risk Phrases R61
Safety Phrases 53-22-36/37-45-16-7
RIDADR UN 1544 6.1/PG 3
RTECS QD1924200

~%

5985-38-6 structure

5985-38-6

Literature: MALLINCKRODT INC. Patent: WO2006/23669 A2, 2006 ; Location in patent: Page/Page column 5-8 ;
Precursor  1

DownStream  0